Our collective findings revealed that the increased T cell function and infiltration into tumors in response to compound 968, and the inhibition of glutaminase by compound 968, helped to improve the treatment effect of immune checkpoint blockade in ovarian cancer. This evidence concerns the gene GLS and ovarian cancer.